(Total Views: 123)
Posted On: 11/27/2018 7:23:39 PM
Post# of 154159
NetworkNewsBreaks – CytoDyn Inc. (CYDY) Scheduled to Present at Two Conferences in December
CytoDyn (OTCQB: CYDY), a biotechnology company developing a novel humanized CCR5 monoclonal antibody for multiple therapeutic indications, this morning announced that Nader Pourhassan, Ph.D., president and CEO and Richard Pestell, M.D., Ph.D., F.A.C.P., M.B.A., Chief Medical Officer, will present at two investment conferences during the month of December. First, taking place on Tuesday, December 4, 2018 at 1:30 p.m. ET, the company will present at the 11th Annual LD Micro Main Event at the Luxe Sunset Boulevard Hotel in Los Angeles. On Thursday, December 13, 2018, the company will present at the Singular Research “Best of the Uncovered” – Small Cap 13th Annual Conference 2018 being held in San Francisco. A live webcast and replay of the company’s presentation at the LD Micro Main Event will be available on the investors section of CytoDyn’s website.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
CytoDyn (OTCQB: CYDY), a biotechnology company developing a novel humanized CCR5 monoclonal antibody for multiple therapeutic indications, this morning announced that Nader Pourhassan, Ph.D., president and CEO and Richard Pestell, M.D., Ph.D., F.A.C.P., M.B.A., Chief Medical Officer, will present at two investment conferences during the month of December. First, taking place on Tuesday, December 4, 2018 at 1:30 p.m. ET, the company will present at the 11th Annual LD Micro Main Event at the Luxe Sunset Boulevard Hotel in Los Angeles. On Thursday, December 13, 2018, the company will present at the Singular Research “Best of the Uncovered” – Small Cap 13th Annual Conference 2018 being held in San Francisco. A live webcast and replay of the company’s presentation at the LD Micro Main Event will be available on the investors section of CytoDyn’s website.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)
